These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods. Werk T; Volkin DB; Mahler HC Eur J Pharm Sci; 2014 Mar; 53():95-108. PubMed ID: 24370624 [TBL] [Abstract][Full Text] [Related]
5. How subvisible particles become invisible-relevance of the refractive index for protein particle analysis. Zölls S; Gregoritza M; Tantipolphan R; Wiggenhorn M; Winter G; Friess W; Hawe A J Pharm Sci; 2013 May; 102(5):1434-46. PubMed ID: 23463514 [TBL] [Abstract][Full Text] [Related]
6. Collaborative Study for Analysis of Subvisible Particles Using Flow Imaging and Light Obscuration: Experiences in Japanese Biopharmaceutical Consortium. Kiyoshi M; Shibata H; Harazono A; Torisu T; Maruno T; Akimaru M; Asano Y; Hirokawa M; Ikemoto K; Itakura Y; Iwura T; Kikitsu A; Kumagai T; Mori N; Murase H; Nishimura H; Oda A; Ogawa T; Ojima T; Okabe S; Saito S; Saitoh S; Suetomo H; Takegami K; Takeuchi M; Yasukawa H; Uchiyama S; Ishii-Watabe A J Pharm Sci; 2019 Feb; 108(2):832-841. PubMed ID: 30121316 [TBL] [Abstract][Full Text] [Related]
7. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution. Nayak A; Colandene J; Bradford V; Perkins M J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601 [TBL] [Abstract][Full Text] [Related]
8. Approaches to reducing subvisible particle counts in lyophilized parenteral formulations. Gupta PK; Porembski E; Williams NA J Pharm Sci Technol; 1994; 48(1):30-7. PubMed ID: 8004415 [TBL] [Abstract][Full Text] [Related]
9. The effect of shear and extensional viscosities on atomization of Newtonian and non-Newtonian fluids in ultrasonic inhaler. Broniarz-Press L; Sosnowski TR; Matuszak M; Ochowiak M; Jabłczyńska K Int J Pharm; 2015 May; 485(1-2):41-9. PubMed ID: 25735665 [TBL] [Abstract][Full Text] [Related]
10. Subvisible Particle Analysis of 17 Monoclonal Antibodies Approved in China Using Flow Imaging and Light Obscuration. Guo S; Yu C; Guo X; Jia Z; Yu X; Yang Y; Guo L; Wang L J Pharm Sci; 2022 Apr; 111(4):1164-1171. PubMed ID: 34551350 [TBL] [Abstract][Full Text] [Related]
11. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress. Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805 [TBL] [Abstract][Full Text] [Related]